APA (7th ed.) Citation

Ge, Y., He, Y., Yu, S., Gao, H., & Sun, P. (2026). Homologous recombination deficiency in high-grade serous ovarian carcinoma: Clinical pathological characteristics, impact of neoadjuvant chemotherapy, and prognostic implications. Journal of Gynecologic Oncology, 37(4), 1. https://doi.org/10.3802/jgo.2026.37.e73

Chicago Style (17th ed.) Citation

Ge, Yunjie, Yangyang He, Shili Yu, Hongwen Gao, and Ping-Li Sun. "Homologous Recombination Deficiency in High-grade Serous Ovarian Carcinoma: Clinical Pathological Characteristics, Impact of Neoadjuvant Chemotherapy, and Prognostic Implications." Journal of Gynecologic Oncology 37, no. 4 (2026): 1. https://doi.org/10.3802/jgo.2026.37.e73.

MLA (9th ed.) Citation

Ge, Yunjie, et al. "Homologous Recombination Deficiency in High-grade Serous Ovarian Carcinoma: Clinical Pathological Characteristics, Impact of Neoadjuvant Chemotherapy, and Prognostic Implications." Journal of Gynecologic Oncology, vol. 37, no. 4, 2026, p. 1, https://doi.org/10.3802/jgo.2026.37.e73.